1. Home
  2. CBFV vs NYXH Comparison

CBFV vs NYXH Comparison

Compare CBFV & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CB Financial Services Inc.

CBFV

CB Financial Services Inc.

N/A

Current Price

$36.33

Market Cap

184.7M

Sector

Finance

ML Signal

N/A

Logo Nyxoah SA

NYXH

Nyxoah SA

HOLD

Current Price

$1.40

Market Cap

161.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CBFV
NYXH
Founded
1901
2009
Country
United States
Belgium
Employees
N/A
N/A
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
184.7M
161.9M
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
CBFV
NYXH
Price
$36.33
$1.40
Analyst Decision
Buy
Strong Buy
Analyst Count
3
3
Target Price
$38.00
$9.33
AVG Volume (30 Days)
3.3K
187.2K
Earning Date
04-22-2026
05-12-2026
Dividend Yield
3.12%
N/A
EPS Growth
N/A
N/A
EPS
0.73
N/A
Revenue
$43,557,000.00
N/A
Revenue This Year
$48.93
$213.98
Revenue Next Year
$7.97
$126.25
P/E Ratio
$49.18
N/A
Revenue Growth
N/A
N/A
52 Week Low
$30.00
$1.26
52 Week High
$38.86
$8.59

Technical Indicators

Market Signals
Indicator
CBFV
NYXH
Relative Strength Index (RSI) 48.26 30.65
Support Level $34.06 $1.26
Resistance Level $36.44 $1.70
Average True Range (ATR) 0.75 0.08
MACD -0.16 0.01
Stochastic Oscillator 26.20 10.84

Price Performance

Historical Comparison
CBFV
NYXH

About CBFV CB Financial Services Inc.

CB Financial Services Incis a bank holding company headquartered in Carmichaels, Pennsylvania. The company had one reportable segment, community banking services. The Bank also has a loan production office in Allegheny County, a loan production office and a corporate center in Washington County, and an operations center in Greene County, Pennsylvania. The Bank is a community-oriented institution offering residential and commercial real estate loans, commercial and industrial loans, and consumer loans, as well as a variety of deposit products for individuals and businesses in its market area.

About NYXH Nyxoah SA

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

Share on Social Networks: